Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Beyond Transfusion: Current Treatment Options for Managing Thalassem…

Abdulrahman Nasiri

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red Cell …

Insights from 2023 ASH Annual Meeting

K. Kuo

ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Causing …

Insights from 2023 ASH Annual Meeting

L. Bilston

Mitapivat in Adults With Alpha- or Beta-Non-Transfusion-Dependent Th…

Ali Taher

The Role of Luspatercept in Transfusion-Dependent Patients With Beta…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Tombak

Importance of PK Activation in Thalassemias

Ilham Youssry

Thalassemia Intermedia: Cases and Discussion

XV Eurasian Hematology-Oncology Congress - EHOC 2024

J. Abiyounis

Luspatercept and Blood Transfusion Management in Beta Thalassemia an…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

A. Tombak

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

ASH 2022 Conference Coverage

M. Walters

Bu-Cy or Treosulfan-Flu-Thiotepa-Based Myeloablative Conditioning fo…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Bayram

Supportive Management of Thalassemia With Complications: A Case Pres…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Karadaş

A Case of Thalassemia Minor Coexisting with Chronic Myeloproliferati…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Buyukasik